Share on LinkedInShare on LinkedIn

ARTICLE · 03 SEPTEMBER 2026

Verisk v. AccuLynx – Implications For Antitrust Approval

Axinn
Axinn
Contributor
Axinn

Axinn

Incisive. Inclusive. Invested. We’re Axinn. Experienced, tenacious, and always trial-ready, we are...

View firm profile
Explore more from Axinn

On August 7, 2026, the Delaware Court of Chancery ordered Verisk Analytics, Inc. to move forward with its purportedly terminated $2.35 billion proposed acquisition of AccuLynx.com.

United StatesAntitrust/Competition Law

On August 7, 2026, the Delaware Court of Chancery ordered Verisk Analytics, Inc. to move forward with its purportedly terminated $2.35 billion proposed acquisition of AccuLynx.com. The Court concluded that Verisk’s termination of the transaction was invalid and ordered specific performance. That remedy is extraordinary—and rarely ordered—in the M&A context, particularly where the parties must still substantially comply with a costly and time-consuming Second Request issued by the FTC and wait until expiration or termination of the applicable waiting period before they can close. Indeed, it has been nearly 18 years since Hexion v. Huntsman, the last significant “busted deal” litigation where a buyer was ordered to specifically perform its obligations to satisfy a regulatory approval covenant.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from